Jiannan Chen
Jiangsu Key Laboratory For Molecular And Medical Biotechnology
Nanjing, 210023, China
Nanjing, 210023, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Cascading Attrition of In Vivo CAR-T Therapy: From Systemic Delivery Failure to Functional Collapse.
Cascading Attrition of In Vivo CAR-T Therapy: From Systemic Delivery Failure to Functional Collapse.
Journal: Critical reviews in oncology/hematology
Published: May 26, 2026
Next-Generation CAR-T Therapies: From Personalized Anticancer Drugs to Broadly Applicable Disease-Modifying Treatments.
Journal: Transplantation and cellular therapy
Published: April 03, 2026
In Vivo Generation of CAR-T Cells: Current Obstacles, Strategic Solutions, and Clinical Translation.
In Vivo Generation of CAR-T Cells: Current Obstacles, Strategic Solutions, and Clinical Translation.
Journal: Critical reviews in oncology/hematology
Published: March 25, 2026
Oxidative stress in CAR-T cell therapy: Mechanistic insights and redox-targeted interventions.
Journal: Critical reviews in oncology/hematology
Published: October 29, 2025
Envirotune-CAR-T: a hypoxia-responsive and glutamine-enhanced CAR-T cell therapy for overcoming tumor microenvironment-mediated suppression.
Journal: Journal for immunotherapy of cancer
Published: September 24, 2025
Sodium valproate drives propionylation-mediated epigenetic reprogramming to enhance mesothelin CAR-T cell therapy in solid tumors.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 26, 2025
Protein post-translational modifications in CAR-T cells: Novel strategies to amplify antitumor efficacy via epigenetic and metabolic circuitry.
Journal: Critical reviews in oncology/hematology
Published: August 13, 2025
CCR2/CXCR6 enhances tumor infiltration and antitumor efficacy of MSLN CAR-T cells.
Journal: Cellular and molecular life sciences : CMLS
Published: July 24, 2025
Microbiota-derived butyrate potentiates MSLN CAR-T cell therapy by metabolic reprogramming and extracellular matrix remodeling.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 17, 2025
Bisphenol E Neurotoxicity in Zebrafish Larvae: Effects and Underlying Mechanisms.
Journal: Biology
Published: June 17, 2025
Glutamine-driven metabolic reprogramming promotes CAR-T cell function through mTOR-SREBP2 mediated HMGCS1 upregulation in ovarian cancer.
Journal: Journal of translational medicine
Published: May 04, 2025
Last Updated: 09/26/2026